Search

Found 318 Results
Page 1 of 32

General meetings 2020


>search-en COMBINED  GENERAL MEETINGS OF 29 MAY 2020 (1ST CALL) AND OF 19 JUNE 2019 (2ND CALL) Due to the […]

03/30/2020


Annual General Meetings 2019-EN


Ordinary General Meetings of April 26, 2019 (1st call) and May 22, 2019 (2nd call) 2019/05/22 –Press release on the […]


Annual General Meetings 2020


>search-en Combined Ordinary and Extraordinary General Meetings of May 29, 2020 (1st call) and June 19, 2020 (2nd call) Due […]


Onxeo Will Publish Its Annual Results on April 17, 2020


The Annual General Meeting will be held on May 29, 2020 Paris (France), March 27, 2020 – 8:30 pm CET […]

Tags:

03/27/2020


COVID-19-EN


CONTINUITY PLAN – COVID-19 Onxeo continues its activities during the COVID-19 pandemic Dear shareholders, dear partners, In these difficult times, […]

03/23/2020


Onxeo to Present Next-Generation PARP inhibitor, OX401, at the European ESMO-TAT Congress 2020


Paris (France), February 27, 2020 – 5:45 pm CET – Onxeo S.A. (Euronext Paris, NASDAQ Copenhagen: ONXEO), (“Onxeo” or “the […]

Tags:

02/27/2020


Onxeo Enters into Settlement Agreement with SpePharm and SpeBio


Settlement agreement fully resolves long-lasting litigation between the parties and all related proceedings Settlement terms have no impact on Onxeo’s […]

Tags:

02/11/2020


“La France bouge” – Europe 1 : Interview of Judith Greciet


(in French only)   Watch the interview  

Tags:

02/04/2020


Onxeo Enters Clinical Research Agreement with Gustave Roussy to Conduct Clinical Trial of AsiDNA™ for Treatment of Relapsed Ovarian Cancer


The REVOCAN phase 1b/2 study, sponsored by Gustave Roussy, will evaluate the effect of AsiDNA™ on the acquired resistance to […]

Tags:

01/29/2020


Onxeo to Present Next-Generation PARP inhibitor, OX401, at PARP & DDR Inhibitors Summit 2020


Paris (France), January 28, 2020 – 5:45 pm CET – Onxeo S.A. (Euronext Paris, NASDAQ Copenhagen: ONXEO), (“Onxeo” or “the […]

Tags:

01/28/2020


Page 1 of 32

No more results

Last updated on